Background Chemotherapy is a first-line treatment for advanced and metastatic bladder
cancer, but the unsatisfactory objective response rate to this treatment yields poor 5-year …

The number of older patients with cancer is increasing as a result of the ageing of Western
societies. Immune checkpoint inhibitors have improved cancer treatment and are associated …

Diet is the only known intervention which has been conclusively shown to extend life span. It
can be argued the key role diet has to play in the aging process came to prominence as a …

Purpose: Dose-dense methotrexate-vinblastine-adriamycin-cisplatin (ddMVAC) and
gemcitabine-cisplatin (GC) are accepted neoadjuvant regimens for muscle-invasive bladder …

Objective To describe the natural history of untreated muscle‐invasive bladder cancer
(MIBC) and compare the oncological outcomes of treated and untreated patients. Patients …

Objective To assess diagnostic validity and reliability of VI-RADS in predicting muscle
invasion by bladder cancer (BCa) and evaluate reviewer acceptance of VI-RADS for clinical …

Artesunate is a kind of derivative of artemisinin, which possesses potent anti-cancer effect in
addition to its anti-malarial property. And autophagy was a highly conserved process …

Although muscle-invasive bladder cancer is commonly treated with radical cystectomy, a
standard alternative is bladder preservation therapy, consisting of maximum transurethral …

Background Urothelial carcinoma (UC) is a common malignancy with significant associated
mortality. Recent clinical trials suggest an emerging role for HER2-targeted therapy. Testing …

Although the majority of bladder cancer literature has been dedicated to optimizing
oncological outcomes and focuses on physical prognostic criteria such as nutritional and …